Zealthy Review 2026: Semaglutide, Tirzepatide, and the Real Cost

What does Zealthy actually offer for weight loss?

Zealthy isn't a single-product company — it's a broader telehealth platform (it also treats things like anxiety, hair loss, and erectile dysfunction) with a weight-loss track that splits into two genuinely different paths. The first is compounded medication: semaglutide or tirzepatide prepared by a pharmacy under an individual prescription, priced separately from the platform's monthly membership. The second is a brand-name path, where a coordination team tries to get your insurance to cover FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro instead.

That second option is what sets Zealthy apart from purely compounded-first competitors. Rather than defaulting everyone to a compounded product, Zealthy's marketing leans on insurance navigation — checking your plan's formulary, filing prior authorizations, and aiming for a copay as low as $25/mo if your plan covers the brand. If it doesn't, you're billed the drug's own cash price on top of the membership, which for either brand typically runs well above the compounded ceiling — so the $25 figure is best treated as a best-case number, not a starting assumption.

Compounded semaglutide vs. tirzepatide vs. the brand-name track — which one is right for you?

Compounded semaglutide is the lower-cost entry point, starting around $151/mo on top of the membership. It's the same active mechanism as Ozempic and Wegovy — a GLP-1 receptor agonist that slows digestion and reduces appetite — just prepared by a compounding pharmacy rather than manufactured and FDA-reviewed as a finished drug. It's the more established of the two molecules, with the longer clinical track record.

Compounded tirzepatide starts higher, around $216/mo on top of membership, reflecting its dual GIP/GLP-1 mechanism — the same one behind Mounjaro and Zepbound. Patients considering it are usually choosing between a somewhat higher starting price and a medication class associated with a larger average effect. Neither figure is guaranteed to hold as your dose increases; Zealthy's own marketing uses "as low as" language for both, which is a signal that higher-dose tiers likely cost more, even though the company doesn't publish the full ladder.

The brand-name track is a different trade entirely — you're not choosing a molecule, you're choosing certainty. Wegovy, Zepbound, Ozempic, and Mounjaro went through full FDA review as finished drugs, with manufacturing and quality oversight that a compounded product doesn't carry. The catch is cost: without insurance coverage, brand-name pricing sits meaningfully above even the higher compounded tier, which is exactly why Zealthy leads with the insurance-coordination pitch for this path rather than a flat price.

What does Zealthy really cost, membership fee included?

The number that's easy to miss in Zealthy's ads is the membership fee. Every weight-loss patient pays $135/mo for the platform itself — provider access, coaching, and insurance coordination — separately from whatever the medication costs. Zealthy frequently discounts the first month, commonly to somewhere between $39 and $49, which is the figure that tends to show up in ads. Budget against the $135 ongoing rate, not the introductory one.

Add the medication and the starting all-in price lands around $286/mo for compounded semaglutide or $351/mo for compounded tirzepatide — membership plus medication, at the lowest advertised dose. Over a year, that's roughly $3,400 to $4,200, and likely higher once you're titrated to a maintenance dose, since Zealthy doesn't publish what higher tiers cost. Patients purchasing a 3-month medication supply get 20% off the next two months of membership fees, which softens the math somewhat if you're comfortable committing upfront.

One structural point worth naming plainly: that $135/mo membership fee is not something every competitor charges. Henry Meds bundles everything — provider visit, medication, shipping — into one flat monthly price with no separate membership layer, which is a meaningfully simpler bill to reconcile.

Is Zealthy legitimate — and what's the DOJ lawsuit about?

Yes, in the narrow sense that matters first: Zealthy runs a real intake, routes your case to a licensed provider, and dispenses through a state-licensed pharmacy network rather than an unregulated supplement seller. That's a meaningfully different thing from a scam with no clinical process behind it.

But Zealthy carries more legal and regulatory weight than most companies in this category, and it's worth understanding in plain terms rather than skimming past.

The FDA warning letter

On September 9, 2025, the FDA sent a warning letter to FitRX, LLC dba Zealthy, over website language stating that semaglutide is the active ingredient in Wegovy and Ozempic and describing it as "more cost effective" without the required context — phrasing the agency said implied Zealthy's compounded product was equivalent to the FDA-approved brands. It's a marketing-language violation, not a finding that the underlying medication is unsafe, and it's a version of the same letter the FDA has sent to dozens of GLP-1 telehealth companies over similar claims.

The DOJ and FTC lawsuit — and the asset freeze motion

This is the caveat that actually distinguishes Zealthy from most of its competitors. In June 2024, the Department of Justice and FTC sued a group of telehealth companies — including Zealthy, its corporate predecessor Gronk Inc., and founder Kyle Robertson — alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act: hiding subscription terms before collecting payment information, billing without clear consent, and making cancellation deliberately difficult. Robertson previously ran Cerebral, which settled a similar FTC case over subscription billing; prosecutors allege the pattern continued at Zealthy.

The case has escalated since. A third amended complaint filed in April 2026 added allegations that non-clinician staff issued prescriptions using physicians' National Provider Identifier numbers without those physicians' knowledge or review — the government's filing describes one physician's identity being used on numerous prescriptions he never evaluated. On the strength of that filing, the DOJ asked the court for an emergency asset freeze and the appointment of a receiver over Zealthy, arguing the company's available funds may fall short of its exposure in the case. That motion was still pending as this review was written, and none of the allegations have been proven in court — but a going-concern risk of this kind is genuinely different from an ordinary customer-service complaint, and it belongs in your decision, not buried in fine print.

Separately, Novo Nordisk sued Zealthy in August 2025 over marketing language it argued implied FDA-approval-level equivalence for the compounded product — a private company defending its own brand, distinct from the federal case above. Court-tracking records show the core claims in that suit were narrowed on a motion to dismiss; confirm the docket's current status if it factors into your decision.

What do real Zealthy customers say?

The Trustpilot picture is polarized rather than middling: Zealthy sits around 3.2 out of 5 from roughly 5,900 reviews, split almost evenly between five-star praise (fast approval, real weight loss, responsive coaching) and one-star complaints. The BBB doesn't assign Zealthy a letter grade — its profile shows "Not Rated" while the company works through a backlog — but it carries an active pattern-of-complaints alert and roughly 2,500 closed complaints over the past three years, the large majority centered on billing: charges continuing after a stated cancellation, refund requests denied on "all sales final" grounds, and a number of customers reporting charges appearing under an unfamiliar name they didn't immediately recognize on their statement. That pattern lines up closely with what the DOJ's complaint alleges at scale, which is worth sitting with rather than dismissing as isolated noise.

How the Zealthy process works, step by step

• Complete an online intake covering weight history, medical conditions, and current medications, plus your insurance information if you want the brand-name path explored
• A licensed provider reviews your intake and, if appropriate, prescribes compounded semaglutide, compounded tirzepatide, or a brand-name alternative
• For the brand-name path, Zealthy's coordination team checks your formulary and files any needed prior authorization before you're billed
• For the compounded path, your prescription routes to a pharmacy in Zealthy's network — the company doesn't publicly name which one
• Medication ships to your address, and an assigned coach is available for unlimited async messaging on dosing questions and check-ins
• The $135/mo membership renews automatically until you cancel through your account's "Manage Membership" setting

Zealthy vs. Mochi Health and Henry Meds

Structurally, Zealthy has more in common with Mochi Health than with Henry Meds — both charge a separate membership fee on top of medication, rather than one flat all-in price. Mochi's membership is cheaper at $79/mo versus Zealthy's $135/mo, and Mochi requires its physician network to hold ABOM obesity-medicine board certification, a credential Zealthy doesn't specifically advertise. Mochi's own pharmacy track record has had a real stumble (a 2025 compounding-facility shutdown), but it doesn't carry anything resembling Zealthy's current federal litigation.

Henry Meds skips the membership question entirely — one flat monthly price covers the provider visit, medication, and shipping, with oral and injectable formats for both molecules. It's arguably the simpler bill of the three, though it doesn't offer Zealthy's insurance-coordination path to brand-name drugs. For patients who specifically want to stay on the FDA-approved brand rather than a compounded version, Ro is a closer comparison — it's a branded-only model with labs and coaching bundled into its own membership, without a compounded track at all. For a fuller side-by-side of menopause-adjacent GLP-1 telehealth options, see the menopause telehealth comparison.

Who Zealthy fits — and who should look elsewhere

Zealthy works reasonably well for a specific patient: someone comfortable with a compounded medication, or someone who specifically wants help navigating insurance toward a brand-name drug, who is willing to read the fine print on billing and keep an eye on their statement.

• Cost-driven and compounded-comfortable — the starting price on compounded semaglutide or tirzepatide is competitive with the category, even after the membership fee
• Wants a real shot at insurance covering brand-name Wegovy or Zepbound — the coordination team is a genuine differentiator most compounded-only competitors don't offer
• Comfortable monitoring their own billing closely — given the volume of billing-related complaints and the active federal case, checking your statement each month and confirming cancellation in writing is a reasonable precaution here, more than at most competitors
• Better served elsewhere: patients who want a single flat fee with no separate membership (Henry Meds), ABOM-certified obesity-medicine specialists specifically (Mochi Health), a branded-only model with no compounded option (Ro), or simply a platform without an active DOJ asset-freeze motion hanging over it right now

What to check before you enroll

None of this means avoid Zealthy outright — plenty of patients do get real medication, real provider access, and real results here. It means the diligence is worth doing upfront rather than after your card is on file.

• Get your specific medication, dose, and ongoing monthly price in writing — the discounted first-month figure isn't what you'll pay long-term
• Confirm your state is actually covered during intake — Zealthy advertises all 50 states, but at least one independent tracker reports narrower functional coverage
• Ask which pharmacy is filling your prescription and confirm its current state licensure, since Zealthy doesn't name its compounding partner publicly
• If you're going the brand-name/insurance route, get the coordination team's estimate of your likely copay in writing before assuming the $25 figure applies to you
• Screenshot or save your cancellation confirmation, and watch your statement for charges under an unfamiliar name — this is the exact pattern both customer complaints and the DOJ's case describe
• Read the current status of the DOJ's asset-freeze motion before committing to a multi-month prepay discount, since a receivership could affect ongoing service